ABEONA THERAPEUTICS INC. - Common Stock, par value $0.01 (ABEO)

CUSIP: 00289Y206

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Common Stock, par value $0.01
Shares outstanding
56,742,057
Total 13F shares
30,142,466
Share change
+15,693,871
Total reported value
$127,804,658
Put/Call ratio
5.4%
Price per share
$4.24
Number of holders
47
Value change
+$64,543,759
Number of buys
37
Number of sells
27

Quarterly Holders Quick Answers

What is CUSIP 00289Y206?
CUSIP 00289Y206 identifies ABEO - ABEONA THERAPEUTICS INC. - Common Stock, par value $0.01 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ABEO - ABEONA THERAPEUTICS INC. - Common Stock, par value $0.01 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F 3/4/5
Company · 10%+ Owner
5.7%
3,249,994
$23,562,457 31 Mar 2024
Nantahala Capital Management, LLC
13F
Company
4.1%
2,310,640
$16,752,140 31 Mar 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
3.5%
1,986,548
$14,402,473 31 Mar 2024
13F
Adage Capital Management, L.P.
3/4/5
10%+ Owner
class O/S missing
2,948,475
$11,999,998 07 May 2024
Western Standard LLC
13F
Company
2.4%
1,361,489
$9,870,795 31 Mar 2024
13F
VANGUARD GROUP INC
13F
Company
1.9%
1,101,958
$7,989,195 31 Mar 2024
13F
Ikarian Capital, LLC
13F
Company
1.6%
888,593
$6,442,299 31 Mar 2024
13F
Laurion Capital Management LP
13F
Company
1.1%
646,830
$4,689,518 31 Mar 2024
13F
CITIGROUP INC
13F
Company
0.85%
484,054
$3,509,392 31 Mar 2024
13F
Steven H. Rouhandeh
3/4/5
Director, 10%+ Owner
mixed-class rows
582,674
mixed-class rows
$2,726,645 25 May 2021
Edward Carr
3/4/5
Chief Financial Officer
class O/S missing
400,169
$2,044,864 08 Oct 2021
BOOTHBAY FUND MANAGEMENT, LLC
13F
Company
0.48%
270,340
$1,959,965 31 Mar 2024
13F
Walleye Capital LLC
13F
Company
0.47%
266,114
$1,929,327 31 Mar 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.43%
241,791
$1,753,416 31 Mar 2024
13F
BlackRock Finance, Inc.
13F
Company
0.39%
220,549
$1,598,981 31 Mar 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.3%
171,533
$1,243,614 31 Mar 2024
13F
MARSHALL WACE, LLP
13F
Company
0.23%
128,903
$934,548 31 Mar 2024
13F
NORTHERN TRUST CORP
13F
Company
0.23%
128,701
$933,082 31 Mar 2024
13F
Bank of New York Mellon Corp
13F
Company
0.21%
119,019
$862,885 31 Mar 2024
13F
STATE STREET CORP
13F
Company
0.15%
85,995
$623,464 31 Mar 2024
13F
Man Group plc
13F
Company
0.13%
73,824
$535,224 31 Mar 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.13%
73,837
$535,000 31 Mar 2024
13F
Qube Research & Technologies Ltd
13F
Company
0.13%
72,798
$527,786 31 Mar 2024
13F
HRT FINANCIAL LP
13F
Company
0.12%
69,051
$500,000 31 Mar 2024
13F
JANE STREET GROUP, LLC
13F
Company
0.11%
64,511
$467,705 31 Mar 2024
13F
BARCLAYS PLC
13F
Company
0.1%
56,394
$408,857 31 Mar 2024
13F
MORGAN STANLEY
13F
Company
0.05%
31,035
$225,005 31 Mar 2024
13F
LPL Financial LLC
13F
Company
0.05%
30,540
$221,415 31 Mar 2024
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.05%
27,466
$199,129 31 Mar 2024
13F
Jump Financial, LLC
13F
Company
0.04%
25,440
$184,440 31 Mar 2024
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.04%
24,561
$178,000 31 Mar 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.04%
23,009
$166,816 31 Mar 2024
13F
J. Goldman & Co LP
13F
Company
0.04%
22,750
$164,938 31 Mar 2024
13F
JPMORGAN CHASE & CO
13F
Company
0.04%
21,664
$157,065 31 Mar 2024
13F
BALYASNY ASSET MANAGEMENT L.P.
13F
Company
0.03%
19,026
$137,939 31 Mar 2024
13F
Engineers Gate Manager LP
13F
Company
0.03%
17,760
$128,760 31 Mar 2024
13F
Tower Research Capital LLC (TRC)
13F
Company
0.03%
16,140
$117,015 31 Mar 2024
13F
Creative Planning
13F
Company
0.03%
15,005
$108,786 31 Mar 2024
13F
Squarepoint Ops LLC
13F
Company
0.03%
14,520
$105,270 31 Mar 2024
13F
Palumbo Wealth Management LLC
13F
Company
0.03%
14,368
$104,168 31 Mar 2024
13F
Y-Intercept (Hong Kong) Ltd
13F
Company
0.02%
14,023
$101,667 31 Mar 2024
13F
Corient Private Wealth LLC
13F
Company
0.02%
13,902
$100,790 31 Mar 2024
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
0.02%
12,634
$91,000 31 Mar 2024
13F
OMERS ADMINISTRATION Corp
13F
Company
0.02%
12,400
$89,900 31 Mar 2024
13F
Mann Paul Elliot
3/4/5
Director
class O/S missing
16,907
$86,395 26 Sep 2022
Todd Wider
3/4/5
Director
class O/S missing
16,907
$86,395 26 Sep 2022
UBS Group AG
13F
Company
0.02%
10,457
$75,814 31 Mar 2024
13F
SIMPLEX TRADING, LLC
13F
Company
0%
2,154
$15,000 31 Mar 2024
13F
GROUP ONE TRADING LLC
13F
Company
0%
1,757
$12,738 31 Mar 2024
13F
OSAIC HOLDINGS, INC.
13F
Company
0%
1,105
$8,011 31 Mar 2024
13F

Institutional Holders of ABEONA THERAPEUTICS INC. - Common Stock, par value $0.01 (ABEO) as of Q2 2024

As of 30 Jun 2024, ABEONA THERAPEUTICS INC. - Common Stock, par value $0.01 (ABEO) was held by 47 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 30,142,466 shares. The largest 10 holders included SUVRETTA CAPITAL MANAGEMENT, LLC, Nantahala Capital Management, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, Vivo Capital, LLC, Rosalind Advisors, Inc., Western Standard LLC, Laurion Capital Management LP, and Propel Bio Management, LLC. This page lists 47 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
55
Q2 2024 holders
47
Holder diff
-8
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 Value $ Q2 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.